Artificial Intelligence (AI) has revolutionized drug discovery by assisting researchers with quick information searches. Sifting through vast databases, pattern recognition, virtual screening, and predictive modeling of new molecules has always been challenging. However, AI hallucinates up to 30% of the time, which is intolerable in the critical drug discovery domain.
